Our skin protects us from everyday mechanical stresses, like friction, cuts, and impacts. A key part of this ...
As age increases, the pancreas changes, which increases the risk of metabolic diseases such as type 2 diabetes, digestive ...
The development could help scientists develop patient-specific treatments and one day offer a lab-grown lung transplant ...
Researchers have developed a 3D-printed lung tissue model that could help scientists better study and treat diseases.
Carrying excess weight may be doing more than just straining the heart — it could also be ageing your lungs ahead of time, ...
Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will report 2025 third ...
A recent study published in Life Metabolism by researchers from the Affiliated Hospital of Nantong University has identified ...
The Phase 3 study is a global trial to evaluate improvements in both pain and function for up to 12 months following a MOTYS ...
BioLamina CEO Klaus Langhoff-Roos discusses the challenges of scaling stem cell production from lab plates to bioreactors, ...
The idea that retinol thins your skin likely comes from some of the short-term side effects it causes when you first start ...
XORTX Therapeutics Inc. (“XORTX ” or the “Company ”) (NASDAQ: XRTX \| TSXV: XRTX \| Frankfurt: ANU), a late stage clinica ...
Stockhead on MSN
Regenerative medicine is a new frontier for medical tech – and these ASX companies are at the forefront
Regenerative medicine is a fast-growing field harnessing the body’s natural healing ability and has become a focus for several ASX biotechs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback